For this, we used CRISPR/Cas9 in combination with an sgRNA targeting a specific region of the APC gene that frequently harbors protein‐truncating somatic mutations in colorectal cancers (Fig 2H and Appendix Fig S2A). This evidence concerns the gene APC and colorectal cancer.